A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma

Clinical trial NCT00189241 · COMPLETED

Trial details

NCT number: NCT00189241
Sponsor: MEDA Pharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Basal Cell Carcinoma

Start date: 2001-02-01
Primary completion: 2007-02-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.